Assignee
SINOCELLTECH LTD
CN·6 granted patents·16 pending applications·2 citations·filing 2021–2024
Top patents by PatentIndex Score
22 records- 0189US12060416B2Humanized anti-VEGF monoclonal antibodySINOCELLTECH LTD·Filed 2022·Granted Aug 13, 2024·2 cites·9 claims
- 0286US2025122246A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0386US2025109174A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0486US2025145672A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0586US2025101068A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0686US2025171506A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0786US2025136645A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0886US2025122245A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 0986US2025136644A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1086US2025145671A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1186US2025136646A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1286US2025092096A1Chimeric papillomavirus l1 proteinSINOCELLTECH LTD·Filed 2024·Application pending·0 cites
- 1376US12139514B2Chimeric papilloma virus L1 proteinSINOCELLTECH LTD·Filed 2022·Granted Nov 12, 2024·0 cites·8 claims
- 1457US2024075124A1Stable formulation of human papillomavirus virus-like particle vaccineSINOCELLTECH LTD·Filed 2022·Application pending·0 cites
- 1553US12516113B2Humanized anti-IL17A antibody and application thereofSINOCELLTECH LTD·Filed 2022·Granted Jan 6, 2026·0 cites·13 claims
- 1653US12440549B2Polyvalent immunogenicity composition for human papillomavirusSINOCELLTECH LTD·Filed 2022·Granted Oct 14, 2025·0 cites·7 claims
- 1752US12479911B2Humanized anti-VEGF antibody Fab fragmentSINOCELLTECH LTD·Filed 2022·Granted Nov 25, 2025·0 cites·5 claims
- 1851US2023272106A1Stable formulation for recombinant anti-pd-1 monoclonal antibodySINOCELLTECH LTD·Filed 2021·Application pending·0 cites
- 1950US12275790B2Humanized anti-PD-1 antibody and the use thereofSINOCELLTECH LTD·Filed 2021·Granted Apr 15, 2025·0 cites·22 claims
- 2047US2022259316A1Multiple-Variable Dosage Regimen for the Treatment of Cancers with High Expression of EGFRSINOCELLTECH LTD·Filed 2022·Application pending·0 cites
- 2147US2023257469A1TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEINSINOCELLTECH LTD·Filed 2021·Application pending·0 cites
- 2246US2023330220A1Method for improving immunogenicity of protein/peptide antigenSINOCELLTECH LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →